Now livetag icon
The future of market intelligence is here. Meet AI Studio — your AI-powered Similarweb expertLearn morebanner icon
Geistlich Sons

February 2026

Geistlich Sons Market Share Analysis for February 2026

the regeneration expert - geistlich specializes in the regeneration of bone, cartilage and tissue.
Year Founded1851
Employees201 - 500
Annual Revenue$100M - $200M
geistlich.com
Geistlich Sons
Geistlich Sons (including company regionals)
  • geistlich.com
    geistlich.com
See more website traffic and engagement information

Geistlich Sons Revenue up to February 2026 is 100M - 200M

revenue generated by Geistlich Sons top domains

Geistlich Sons top domains revenue over 3 years

Revenue for Geistlich Sons top domains

geistlich.comgeistlich.com100M - 200M
See more with Sales Intelligence

Total visits to Geistlich Sons's top domains

Understand Geistlich Sons market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Geistlich Sons's top domains

Analyze Geistlich Sons engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Geistlich Sons's top domains

See how Geistlich Sons keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Geistlich Sons

These are the website technologies, by industry, used by Geistlich Sons top domains

Advertising (6)

DoubleClick

DoubleClick

Payment & Currencies (4)

PayPal

PayPal

Social (4)

Instagram

Instagram

Widget (4)

Google Maps

Google Maps

More Technologies

13

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Geistlich Sons

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGeistlich Sons Limited sells assets to Perseveretherapeutics.As part of its launch, Persevere has acquired the clinical-stage program and related assets for misetionamide (GP-2250) from Geistlich Pharma AG.
NewsGeistlich Sons Limited partnered with StimLabs LLC. on Nov 1st '24.Geistlich has entered into an exclusive national distribution partnership agreement with StimLabs(R), a leading wound care company in the USA.
NewsGeistlich Sons Limited hired Diego Gabathuler as CEO on Dec 1st '23.Geistlich Pharma AG has appointed Diego Gabathuler as its new CEO effective December 1, 2023.

See all Geistlich Sons signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.